Literature DB >> 27623967

Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.

Basilio Moreno1, Ana B Crujeiras2,3, Diego Bellido4, Ignacio Sajoux5, Felipe F Casanueva6,7.   

Abstract

The long-term effect of therapeutic diets in obesity treatment is a challenge at present. The current study aimed to evaluate the long-term effect of a very low-calorie-ketogenic (VLCK) diet on excess adiposity. Especial focus was set on visceral fat mass, and the impact on the individual burden of disease. A group of obese patients (n = 45) were randomly allocated in two groups: either the very low-calorie-ketogenic diet group (n = 22), or a standard low-calorie diet group; (n = 23). Both groups received external support. Adiposity parameters and the cumulative number of months of successful weight loss (5 or 10 %) over a 24-month period were quantified. The very low-calorie-ketogenic diet induced less than 2 months of mild ketosis and significant effects on body weight at 6, 12, and 24 months. At 24 months, a trend to regress to baseline levels was observed; however, the very low-calorie-ketogenic diet induced a greater reduction in body weight (-12.5 kg), waist circumference (-11.6 cm), and body fat mass (-8.8 kg) than the low-calorie diet (-4.4 kg, -4.1 cm, and -3.8 kg, respectively; p < 0.001). Interestingly, a selective reduction in visceral fat measured by a specific software of dual-energy x-ray absorptiometry (DEXA)-scan (-600 g vs. -202 g; p < 0.001) was observed. Moreover, the very low-calorie-ketogenic diet group experienced a reduction in the individual burden of obesity because reduction in disease duration. Very low-calorie-ketogenic diet patients were 500 months with 5 % weight lost vs. the low-calorie diet group (350 months; p < 0.001). In conclusion, a very low-calorie-ketogenic diet was effective 24 months later, with a decrease in visceral adipose tissue and a reduction in the individual burden of disease.

Entities:  

Mesh:

Year:  2016        PMID: 27623967     DOI: 10.1007/s12020-016-1050-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  54 in total

1.  Anti-obesity drugs: to be or not to be?

Authors:  R V Dvorak; A M Sharma; A Astrup
Journal:  Obes Rev       Date:  2010-11-03       Impact factor: 9.213

2.  A self-regulation program for maintenance of weight loss.

Authors:  Rena R Wing; Deborah F Tate; Amy A Gorin; Hollie A Raynor; Joseph L Fava
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

3.  Words of wisdom. Re: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ. Dietary Intervention Randomized Controlled Trial (DIRECT) Group. N Engl J Med 2008;359:229-41.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Eur Urol       Date:  2009-01       Impact factor: 20.096

Review 4.  A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.

Authors:  B Cabia; S Andrade; M C Carreira; F F Casanueva; A B Crujeiras
Journal:  Obes Rev       Date:  2016-02-24       Impact factor: 9.213

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).

Authors:  Julie-Anne Nazare; Jessica Smith; Anne-Laure Borel; Pablo Aschner; Phil Barter; Luc Van Gaal; Chee Eng Tan; Hans-Ulrich Wittchen; Yuji Matsuzawa; Takashi Kadowaki; Robert Ross; Claire Brulle-Wohlhueter; Natalie Alméras; Steven M Haffner; Beverley Balkau; Jean-Pierre Després
Journal:  Am J Cardiol       Date:  2014-11-13       Impact factor: 2.778

7.  Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain.

Authors:  Felipe F Casanueva; Basilio Moreno; Rosario Rodríguez-Azeredo; Christine Massien; Pedro Conthe; Xavier Formiguera; Vivencio Barrios; Beberly Balkau
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-15       Impact factor: 3.478

Review 8.  The unrelenting fall of the pharmacological treatment of obesity.

Authors:  Guido Di Dalmazi; Valentina Vicennati; Renato Pasquali; Uberto Pagotto
Journal:  Endocrine       Date:  2013-05-16       Impact factor: 3.633

9.  A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men.

Authors:  Matthew J Sharman; William J Kraemer; Dawn M Love; Neva G Avery; Ana L Gómez; Timothy P Scheett; Jeff S Volek
Journal:  J Nutr       Date:  2002-07       Impact factor: 4.798

10.  Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Authors:  Bodil Bjørndal; Lena Burri; Vidar Staalesen; Jon Skorve; Rolf K Berge
Journal:  J Obes       Date:  2011-02-15
View more
  28 in total

1.  Ketogenic diet for weight loss.

Authors:  Rhonda Ting; Nicolas Dugré; G Michael Allan; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

2. 

Authors:  Rhonda Ting; Nicolas Dugré; G Michael Allan; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

3.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

4.  Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis.

Authors:  Marco Castellana; Eleonora Conte; Angelo Cignarelli; Sebastio Perrini; Andrea Giustina; Luca Giovanella; Francesco Giorgino; Pierpaolo Trimboli
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

5.  Confusion in the nomenclature of ketogenic diets blurs evidence.

Authors:  Pierpaolo Trimboli; Marco Castellana; Diego Bellido; Felipe F Casanueva
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 6.  Protein sparing therapies in acute illness and obesity: a review of George Blackburn's contributions to nutrition science.

Authors:  Dylan D Thomas; Nawfal W Istfan; Bruce R Bistrian; Caroline M Apovian
Journal:  Metabolism       Date:  2017-12-07       Impact factor: 8.694

7.  Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?

Authors:  A B Crujeiras; D Gomez-Arbelaez; M A Zulet; M C Carreira; I Sajoux; D de Luis; A I Castro; J Baltar; I Baamonde; A Sueiro; M Macias-Gonzalez; D Bellido; F J Tinahones; J A Martinez; F F Casanueva
Journal:  Int J Obes (Lond)       Date:  2017-06-07       Impact factor: 5.095

8.  Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue.

Authors:  Emily L Goldberg; Irina Shchukina; Jennifer L Asher; Sviatoslav Sidorov; Maxim N Artyomov; Vishwa Deep Dixit
Journal:  Nat Metab       Date:  2020-01-20

9.  A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.

Authors:  Caroline W Cohen; Kevin R Fontaine; Rebecca C Arend; Ronald D Alvarez; Charles A Leath; Warner K Huh; Kerri S Bevis; Kenneth H Kim; John M Straughn; Barbara A Gower
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

Review 10.  The Potential Health Benefits of the Ketogenic Diet: A Narrative Review.

Authors:  Kathryn Dowis; Simran Banga
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.